Concepedia

Michelle Orlick

MO

4

Publications

105

Citations

4

H-Index

2002

Active since

Affiliations

Rutgers Cancer Institute(Current)

Rutgers, The State University of New Jersey

Michelle Orlick is an author at Rutgers Cancer Institute specializing in cancer therapeutics, radiation oncology, and oncology.

Top concepts

Publications per year

2002–2019

4

Publications

4

Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)

Jyoti Malhotra, Salma K. Jabbour, Michelle Orlick et al. · Cancer Treatment and Research Communications · 2019 · 58 citations

, , +5

A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.

Judy Bash-Babula, Deborah Toppmeyer, Marie Labassi et al. · PubMed · 2002 · 24 citations

Modulation of autophagy with hydroxychloroquine in patients with advanced non-small cell lung cancer (NSCLC): A phase Ib study.

Jyoti Malhotra, Salma K. Jabbour, Michelle Orlick et al. · Journal of Clinical Oncology · 2018 · 12 citations

, , +16

Central Nervous System Progression During Systemic Response to Trastuzumab, Humanized Anti-HER-2/neu Antibody, Plus Paclitaxel in a Woman with Refractory Metastatic Breast Cancer

Susan Lindrud, Michelle Orlick, Nicola Barnard et al. · The Breast Journal · 2003 · 11 citations

Rows per page

1–4 of 4